Click Here for 5% Off Your First Aladdin Purchase!

Name And Identifier

ID: ALA1762820

Max Phase: Preclinical

Molecular Formula: C19H25FN6O

Molecular Weight: 372.45

Molecule Type: Small molecule

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

  1. Parent:

    ALA1762820

    ---

Molecule Features

Natural Product: NoChemical Probe: No
Molecule Type: Small moleculeFirst In Class: No
Chirality: NoProdrug: No
Oral: NoParenteral: No
Topical: NoBlack Box: No
Availability: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for Indication

Mechanisms of Action

Mechanism of ActionAction TypeTarget NameTarget TypeTarget OrganismBinding Site Name

Activity Summary

Bioactivity SummaryCount
IC501
LogD1
Assay SummaryCount
B-Binding1
P-Physicochemical1

Properties

Molecular Weight: 372.45Molecular Weight (Monoisotopic): 372.2074
AlogP: 3.31#Rotatable Bonds: 7
Polar Surface Area: 68.44Molecular Species: NEUTRAL
HBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7
HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.06
CX LogP: 3.37CX LogD: 3.37
Aromatic Rings: 3Heavy Atoms: 27
QED Weighted: 0.63Np Likeness Score: -1.51

References

1. Zuev D, Mattson RJ, Huang H, Mattson GK, Zueva L, Nielsen JM, Kozlowski ES, Huang XS, Wu D, Gao Q, Lodge NJ, Bronson JJ, Macor JE..  (2011)  Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.,  21  (8):   [PMID:21411322]

Source

Source(1):

  • Scientific Literature